
FDA ALERT [04/2005] Seroquel is a type of medicine called an atypical antipsychotic. FDA has found that older patients treated with atypical antipsychotics for dementia had a higher chance for death than patients who did not take the medicine. This is not an approved use.
Available forms…
Quetiapine is used to treat schizophrenia and acute manic episodes of bipolar disorder, and is manufactured by AstraZeneca Pharmaceuticals. It affects a wide range of neurotransmitters, including dopamine and serotonin. Quetiapine has been shown to be as effective as standard treatments for each illness.
Quetiapine is effective for the treatment of both positive (e.g., delusions, thought disorder, and hallucinations) and negative (e.g., social withdrawal, lack of energy, apathy, and reduced ability to express emotion) symptoms of schizophrenia. Quetiapine is also effective by itself or in combination with other drugs for the treatment of symptoms that occur in the manic phase of bipolar disorder (e.g., elevated mood, increased physical activity and pressured speech).
Exacerbations are very common in schizophrenia and bipolar disorder. The most frequent cause is due to patients stopping their medication. Therefore you should try to take your medication exactly as prescribed by your healthcare provider.
Quetiapine is usually taken two or three times each day. Generally, doses start low (for example, 25 mg twice daily), and then increase by 50-100 mg every day until 300–400 mg/day is reached around day four for schizophrenia. Higher starting doses (50mg twice a day) are used for bipolar mania. Additional increases may be needed; doses of quetiapine greater than 800 mg/day may sometimes be used by your health care provider. Elderly or very sick patients or those with hepatic impairment may have slower dose increases and lower final targets depending on their tolerability and clinical response
If a dose of quetiapine is missed, take it as soon as you remember to, if it is not too close to when your next dose is due—always discuss this with your health care provider. Do not double your next dose, or take more than what is prescribed.
Quetiapine’s more common side effects are usually relatively minor. Some people may experience sleepiness, low blood pressure or dizziness, especially when standing up suddenly; heart palpitations; daytime sleepiness; dry mouth, weakness, constipation; stomach upset; and headache. Some of these problems may be reduced by increasing the dose slowly and they generally will improve without specific treatment. Patients who already have low blood pressure, have poor liver function, are elderly, or are in a weakened condition may require close monitoring and even more gradual dose changes. Although infrequent, extrapyramidal symptoms (muscle stiffness, tremors, and body shakes) may also occur. At higher doses, the chances for extrapyramidal side effects often increase. Cogentin® (benztropine) or Benadryl® (diphenhydramine) can be prescribed to treat stiffness and tremors.
More serious side effects include weight gain, diabetes, high cholesterol and triglycerides, low thyroid levels, neuroleptic malignant syndrome and tardive dyskinesia. Quetiapine has been shown to cause cataracts (the lens of the eye becomes dull, not clear) in animals. There have been case reports of this side effect when Seroquel is used in high doses in humans. An eye exam may be indicated for people who take high doses of Seroquel.
At the beginning of 2004, the Food and Drug Administration had all manufacturers of atypical antipsychotics include new warnings about each medication being associated with a possible risk of increased blood sugar and diabetes. All adverse effects should be monitored routinely by the professional prescribing treatment and preventive lifestyle changes are often needed.
Tardive dyskinesia (TD) is a side effect that develops with prolonged use of antipsychotics. Medications such as quetiapine have been shown to have a much lower risk of tardive dyskinesia compared to older antipsychotics, such as Haldol® (haloperidol). Should you develop symptoms of tardive dyskinesia, such as grimacing, sucking and smacking of lips, and other movements that you cannot control, contact your healthcare provider immediately.
Because of the risk of tardive dyskinesia, chronic antipsychotic treatment should be reserved for patients with a chronic illness where potentially less harmful treatments are not available or appropriate.
Some medications, such as Luvox® (fluvoxamine) may increase the blood levels of quetiapine. It is possible that patients taking quetiapine with this agent may experience a change in side effects. Tell your doctor if you begin or stop taking Luvox® (fluvoxamine), Biaxin® (clarithromycin), erythromycin, or Nizoral® (ketoconazole), since they may also increase blood levels of quetiapine.
Studies have shown that carbamazepine (Tegretol®; an anticonvulsant commonly used as a mood stabilizer to treat bipolar disorder) can decrease the amount of quetiapine in the blood. Medications with similar effects to carbamazepine include: Mysoline® (primidone), and Dilantin® (phenytoin).
Quetiapine may increase the effects of warfarin and people on this combination may be at greater risk for bruising or bleeding.
It may take at least 2 to 3 weeks in order to see some improvement in your symptoms. The full benefit of quetiapine may not be seen for at least 4-6 weeks.
Updated by Joanne Hawley, Pharm.D, BCPS, BCPP
(December 2006)
NAMI wishes to thank the College of Psychiatric and Neurologic Pharmacists for producing this fact sheet.
For further information please contact the pharmaceutical company listed below.
|
AstraZeneca Pharmaceuticals |
1800 Concord Pike |
302-886-8000 |
Free or low-cost medications provided by pharmaceutical companies
Some pharmaceutical companies offer medication assistance programs to low-income individuals and families. These programs typically require a doctor’s consent and proof of financial status. They may also require that you have either no health insurance, or no prescription drug benefit through your health insurance. Please contact the pharmaceutical company directly for specific eligibility requirements and application information.
Seroquel Rx Assistance Program: 800-424-3727 or www.azandme.com
Copyright © 1996 - 2009 NAMI. All Rights Reserved.